Vial is a next-generation CRO (Contract Research Organization) that is revolutionizing the field of clinical trials. Founded by clinical operations experts and technology leaders, Vial is on a mission to reimagine the way clinical trials are conducted, making them faster, more efficient, and ultimately, more successful. With a focus on empowering scientists to cure all human diseases, Vial offers a range of services in various therapeutic areas such as oncology, dermatology, ophthalmology, gastroenterology, CNS, cardiology, medical device, rare disease, digital therapeutics, and technology.

What sets Vial apart is its end-to-end technology platform, which allows for faster and 50%+ cheaper trials. This is made possible by a team of clinical operations experts and product minds from Silicon Valley who have developed Vial's groundbreaking technology. With a vision to become a leading global, full-service CRO, Vial has raised over $100M and is supported by a team of renowned scientific advisors who contribute to its research advancements